{"id":"vasopressin-methylprednisolone-hydrocortisone","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypertension"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Flushing"},{"rate":"5-10%","effect":"Tachycardia"},{"rate":"1-5%","effect":"Bradycardia"},{"rate":"1-5%","effect":"Hypotension"},{"rate":"0.1-1%","effect":"Cardiac arrest"},{"rate":"0.1-1%","effect":"Arrhythmia"}]},"_chembl":{"chemblId":"CHEMBL2106309","moleculeType":"Small molecule","molecularWeight":"460.57"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Vasopressin works by binding to vasopressin receptors in the body, which triggers a cascade of events leading to vasoconstriction and increased blood pressure. This can be beneficial in certain medical conditions, such as septic shock. However, excessive vasopressin can have negative effects, including vasoconstriction in other areas of the body.","oneSentence":"Vasopressin is a hormone that causes blood vessels to constrict, increasing blood pressure.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:40:15.024Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemorrhagic shock, Septic shock, Diabetes insipidus"},{"name":"Central diabetes insipidus"}]},"trialDetails":[{"nctId":"NCT02785224","phase":"","title":"Arterial Pressure and Stress-Dose Steroids in Cardiac Arrest.","status":"WITHDRAWN","sponsor":"University of Athens","startDate":"2025-12","conditions":"Cardiac Arrest","enrollment":""},{"nctId":"NCT05139849","phase":"PHASE3","title":"VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial","status":"RECRUITING","sponsor":"Tiohundra AB","startDate":"2021-11-17","conditions":"Cardiac Arrest;In-hospital Cardiac Arrest; Methylprednisolone; Vasopressin; Adrenaline; Randomized Clinical Trial","enrollment":1276},{"nctId":"NCT00729794","phase":"PHASE3","title":"Vasopressin, Epinephrine, and Steroids for Cardiac Arrest","status":"COMPLETED","sponsor":"University of Athens","startDate":"2008-09","conditions":"Cardiac Arrest","enrollment":300},{"nctId":"NCT00411879","phase":"PHASE2","title":"Combined Vasopressin, Methylprednisolone, and Epinephrine for Inhospital Cardiac Arrest","status":"COMPLETED","sponsor":"University of Athens","startDate":"2006-06","conditions":"Heart Arrest","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Vasopressin; Methylprednisolone; Hydrocortisone","genericName":"Vasopressin; Methylprednisolone; Hydrocortisone","companyName":"Tiohundra AB","companyId":"tiohundra-ab","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vasopressin is a hormone that causes blood vessels to constrict, increasing blood pressure. Used for Hemorrhagic shock, Septic shock, Diabetes insipidus, Central diabetes insipidus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}